Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Veltmann

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 26, 2020
Correction to: Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registryChristian Veltmann, Stefan Winter, David Duncker, et al.
European Journal of Heart Failure|March 21, 2019
Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled studyUdo Bavendiek, Dominik Berliner, Lukas Aguirre Dávila, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 8, 2020
Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registryChristian Veltmann, Stefan Winter, David Duncker, et al.
Circulation|April 4, 2007
Clinical aspects and prognosis of Brugada syndrome in childrenVincent Probst, Isabelle Denjoy, Paola G Meregalli, et al.
European Journal of Heart Failure|June 25, 2016
Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathyJohann Bauersachs, Mattia Arrigo, Denise Hilfiker-Kleiner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 22, 2023
Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trialUdo Bavendiek, Anika Großhennig, Johannes Schwab, et al.
International Journal of Cardiology|January 21, 2014
ABCC9 is a novel Brugada and early repolarization syndrome susceptibility geneDan Hu, Hector Barajas-Martínez, Andre Terzic, et al.
European Heart Journal|May 10, 2026
Digitoxin in heart failure with reduced ejection fraction according to atrial fibrillation status: the DIGIT-HF trialUdo Bavendiek, Nele Henrike Thomas, Lars S Maier, et al.
Heart Rhythm|September 7, 2010
Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac deathElena Burashnikov, Ryan Pfeiffer, Héctor Barajas-Martinez, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 3, 2023
Prevention of cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation: the ODIn-AF trialJan Wilko Schrickel, Thomas Beiert, Markus Linhart, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 26, 2020
Correction to: Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registryChristian Veltmann, Stefan Winter, David Duncker, et al.
European Journal of Heart Failure|March 21, 2019
Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled studyUdo Bavendiek, Dominik Berliner, Lukas Aguirre Dávila, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 8, 2020
Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registryChristian Veltmann, Stefan Winter, David Duncker, et al.
Circulation|April 4, 2007
Clinical aspects and prognosis of Brugada syndrome in childrenVincent Probst, Isabelle Denjoy, Paola G Meregalli, et al.
European Journal of Heart Failure|June 25, 2016
Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathyJohann Bauersachs, Mattia Arrigo, Denise Hilfiker-Kleiner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 22, 2023
Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trialUdo Bavendiek, Anika Großhennig, Johannes Schwab, et al.
International Journal of Cardiology|January 21, 2014
ABCC9 is a novel Brugada and early repolarization syndrome susceptibility geneDan Hu, Hector Barajas-Martínez, Andre Terzic, et al.
European Heart Journal|May 10, 2026
Digitoxin in heart failure with reduced ejection fraction according to atrial fibrillation status: the DIGIT-HF trialUdo Bavendiek, Nele Henrike Thomas, Lars S Maier, et al.
Heart Rhythm|September 7, 2010
Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac deathElena Burashnikov, Ryan Pfeiffer, Héctor Barajas-Martinez, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 3, 2023
Prevention of cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation: the ODIn-AF trialJan Wilko Schrickel, Thomas Beiert, Markus Linhart, et al.
Pageof 15